Cancer treating drugs market forms the most lucrative sector in pharmaceuticals. As the ageing population continues to rise across the world, the incidence of cancer will continue to grow, leading to increased spending on cancer-treating medicines. This report lists and discusses the top 30 oncology drugs manufacturers.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 157-page report you will receive 83 tables and 64 figures–all unavailable elsewhere.
The 157-page report provides clear detailed insight into the top 30 oncology drugs manufacturers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Download Free Sample Pages of this report
Assessment of the leading companies in the global oncology drugs market. The list below shows some of the companies that are discussed in the report:
- Abbott Laboratories
- Astellas Pharma
- Aurora Biophama
- Boehringer Ingelheim
- Bristol-Myers Squibb (BMS)
- Celgene Corporation
- Eli Lilly
- Fresenius Kabi
- GlaxoSmithKline (GSK)
- Johnson & Johnson
- Jounce Therapeutics
- Other companies
For each company, the report provides information and discussion on:
- Company overview
- Product portfolio
- Recent development
- Financial information
Key questions answered by this report:
- How is the Oncology Drugs Manufacturers market evolving?
- What is driving and restraining the Oncology Drugs Manufacturers market?
- What will be the main driver for the overall market?
- Will leading Oncology Drugs Manufacturers broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- Who are the leading players and what are their prospects over the forecast period?